Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
CAN CSA C22.2 No. 60601-2-4-12 (2016): Technical Requirements for Cardiac Defibrillator Safety and Performance
Comprehensive Guide to the Canadian Standard for Medical Electrical Equipment — Part 2-4: Particular Requirements for Cardiac Defibrillators and External Pacemakers
1. Scope and Applicability
CAN CSA C22.2 No. 60601-2-4-12 (2016) is the Canadian adoption of IEC 60601-2-4:2010, modified for use in Canada under the Canadian Electrical Code, Part 2 (C22.2 series). This standard specifies particular safety and performance requirements for cardiac defibrillators and external pacemakers, including automated external defibrillators (AEDs), semi-automated defibrillators, manual defibrillators, and devices with combined defibrillator/pacemaker functions. It also covers accessories—such as pads, paddles, cables, and batteries—that are essential to the intended operation of these devices.
The scope encompasses all devices intended for clinical use in hospitals, ambulances, and public access settings, as well as devices designed for home use with appropriate training. The standard does not cover implantable defibrillators or external counterpulsation devices. Compliance with CAN CSA C22.2 No. 60601-2-4-12 is mandatory under Canadian regulations for medical electrical equipment marketed or deployed in Canada.
Tip: Although the standard is based on IEC 60601-2-4:2010, manufacturers must consult the Canadian deviations published in the official CSA document. Section-level modifications are provided in Annex ZA to address Canadian electrical safety, language labeling, and climate-specific testing conditions.
2. Key Technical Requirements
The standard establishes essential performance criteria and safety margins that cardiac defibrillators and external pacemakers must meet. Below is a summary of the most critical technical parameters:
| Parameter | Requirement | Test Reference |
|---|---|---|
| Energy output accuracy (manual mode) | Displayed energy ± 2 J or ± 15% (whichever is greater) at all selectable levels | Clause 201.12.1.101 |
| Maximum charge time (new battery) | ≤ 15 s to maximum energy; ≤ 10 s to 200 J | Clause 201.12.1.102 |
| ECG synchronization delay | ≤ 60 ms from R-wave detection to shock delivery | Clause 201.12.4.101 |
| Pulse amplitude (external pacing) | 0 – 200 mA (adjustable in steps ≤ 2 mA) | Clause 201.12.6.101 |
| Pulse duration (external pacing) | 0.1 – 2.0 ms (± 10%) | Clause 201.12.6.102 |
| Patient leakage current (defib shock circuit) | ≤ 0.05 mA (normal condition); ≤ 0.1 mA (single fault) | Clause 201.9.6.2 |
| Environmental operating range | 0 °C to 40 °C; 15% to 95% RH (non-condensing); 700 hPa to 1060 hPa | Clause 201.10.2 |
Important: Energy accuracy must be verified across the entire life of the energy storage device (battery or capacitor). The standard requires manufacturers to provide a test method for verifying that charge times remain within limits after 500 full-energy discharges.
Particular attention is given to the defibrillation waveform. The standard defines requirements for both monophasic and biphasic waveforms, including pulse-tilt limits and delivered energy into a standard 50 Ω test load. Furthermore, all devices must include a synchronized mode for cardioversion, with fallback to an asynchronous mode only if the synchronization circuit fails.
3. Implementation and Testing Considerations
Manufacturers seeking compliance must integrate risk management in accordance with ISO 14971 as part of the design and production process. The standard demands that the manufacturer perform a risk analysis for each essential performance function, including failure modes that could lead to unintended shock delivery, pacing capture failure, or charging delay in emergency situations.
Key Success Factor: Establishing a comprehensive type-test plan early that includes all climatic, mechanical, and electrical tests described in the standard allows for early detection of design gaps. Engage an accredited certification body (e.g., CSA Group, Intertek, or UL) during the design phase to align test setups.
Testing under Canadian conditions often requires extended temperature stress tests (e.g., –20 °C storage) and humidity preconditioning (93% RH at 40 °C for 48 h). Devices must also demonstrate robustness to typical field conditions, such as saline-spray resistance for ambulance-mounted defibrillators and vibration tolerance for portable units.
Critical Compliance Risk: Several device failures leading to field corrections have been traced to insulation breakdown in patient-applied paddles. The standard mandates a high-voltage flash test after the defibrillation output circuit is subjected to 10 repeated maximum-energy shocks. Manufacturers should ensure that all insulation materials, including pad connectors, pass this endurance check.
Software-controlled defibrillators must also comply with the software life‑cycle requirements of IEC 62304, even when the software is considered a separate subsystem. The standard specifically addresses user-interface design for AEDs, requiring audible and visual prompts that are comprehensible even in noisy environments. Voice instructions must be available in at least both official languages (English and French) when marketed in Canada.
4. Compliance and Certification Pathways
To achieve compliance with CAN CSA C22.2 No. 60601-2-4-12 (2016), the manufacturer must first demonstrate conformance to the general standard CAN/CSA-C22.2 No. 60601-1 (Medical electrical equipment — Part 1: General requirements for basic safety and essential performance). The particular standard builds upon that base by adding part‑2‑4 specific tests.
The certification process in Canada is managed by Standards Council of Canada (SCC) accredited certification organizations. These include:
- CSA Group (as the original publisher)
- UL (Underwriters Laboratories)
- Intertek Testing Services
- TÜV SÜD America (with Canadian recognition)
The conformity assessment route generally comprises:
- Review of risk management file (ISO 14971)
- Review of the technical construction file including schematics, bill of materials, instruction manual, and labeling
- Type testing in an accredited laboratory
- Annual factory inspections & follow‑up testing
Manufacturers should be aware that the standard was reaffirmed in 2016 and remains current as of 2026. No significant amendments have been published, but a future update aligned with IEC 60601‑2‑4 Edition 3 is under discussion internationally. It is advisable to monitor CSA Group announcements for any transition periods.
Q: Does CAN CSA C22.2 No. 60601-2-4-12 apply to AEDs used in public access programs?
A: Yes. AEDs are explicitly within scope, including their automatic rhythm analysis algorithms. The standard requires that sensitivity and specificity values for shockable rhythms be disclosed in the instructions for use, and that the device clear a shockable rhythm detection test using the standard test waveforms provided in Annex DD (informative).
A: Yes. AEDs are explicitly within scope, including their automatic rhythm analysis algorithms. The standard requires that sensitivity and specificity values for shockable rhythms be disclosed in the instructions for use, and that the device clear a shockable rhythm detection test using the standard test waveforms provided in Annex DD (informative).
Q: Are there any special requirements for combined defibrillator-external pacemakers?
A: Yes. When a device provides both functions, the standard imposes additional transition safety tests. For example, a defibrillation shock must not cause the pacemaker output circuit to exceed pacing current limits, and the pacemaker must resume normal operation within 2 seconds after the shock is delivered. These tests are detailed in Clause 201.13.101.
A: Yes. When a device provides both functions, the standard imposes additional transition safety tests. For example, a defibrillation shock must not cause the pacemaker output circuit to exceed pacing current limits, and the pacemaker must resume normal operation within 2 seconds after the shock is delivered. These tests are detailed in Clause 201.13.101.
Q: Is it necessary to test the device at Canadian low‑temperature extremes?
A: Canadian deviations in Annex ZA require storage testing at –40 °C and operational testing at –20 °C if the device is intended for unheated ambulance storage or outdoor emergency use. The standard otherwise defines an operating range of 0 °C to 40 °C, but the manufacturer must state the actual intended range and verify performance accordingly.
A: Canadian deviations in Annex ZA require storage testing at –40 °C and operational testing at –20 °C if the device is intended for unheated ambulance storage or outdoor emergency use. The standard otherwise defines an operating range of 0 °C to 40 °C, but the manufacturer must state the actual intended range and verify performance accordingly.